META vs NYT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
META exhibits exceptional fundamental health with a Piotroski F-Score of 8/9, indicating strong financial strength across most key metrics. While the current price of $671.34 trades at a significant premium to the Graham Number ($213.08) and the growth-based Intrinsic Value ($541.67), this is justified by a highly attractive Forward P/E of 18.62 and a PEG ratio of 1.10. The company maintains elite profitability margins (82% Gross, 41.3% Operating) and robust revenue growth of 23.8% YoY. Despite bearish insider sentiment and short-term technical weakness, the underlying operational performance and analyst consensus suggest significant upside toward the $855 target.
The New York Times Company exhibits a stable financial foundation with a Piotroski F-Score of 4/9 and an exceptionally low Debt/Equity ratio of 0.02. However, the stock is severely overvalued, trading at $79.03 despite a Graham Number of $24.36 and an Intrinsic Value of $32.50. This valuation gap is exacerbated by a high PEG ratio of 3.79 and a bearish technical trend (10/100). While earnings beats are consistent, the combination of insider selling by the CEO and CFO and a current price exceeding the analyst target price ($74.11) suggests a significant downside risk.
Compare Another Pair
Related Comparisons
META vs NYT: Head-to-Head Comparison
This page compares Meta Platforms, Inc. (META) and The New York Times Company (NYT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.